Industry reports
Editor highlights

Publication dates

data types

Cancer Drug Market and Forecasts, April 2014

You might be interested in: drug, cancer, clinical trial, more »


 
1-10 of about 200 reports for Cancer Drug

The Indian Cancer Drug and Drug Market : Sectors Brief

  • Industry report
  • May 2012
  • 2 pages

... Medecins sans frontieres says. Cipla, which has been embroiled in a legal dispute with bayer over its right to produce nexavar, said cancer drugs were a small part of its business and the price cuts would ...

Cancer Drug Business in The United States and Japan

  • Industry report
  • January 2013
  • 6 pages

... Proliferation that lead to cell stasis and death. Browse full report with toc: - market.Html according to world health organization ...

U.S. Drug Industry Brief

  • Industry report
  • April 2012
  • 3 pages

... Questions: link on recent shortages in cancer-drug supply in february, the united states came within weeks of running out of preservative-free methotrexate, a generic drug that is an essential ...

U.S. Drug and Medication Business : Innovation and Technology Trends

  • Industry report
  • April 2013
  • 47 pages

... Cycle of cancer drugs: utilization tends to increase steadily after fda approval, peak about 6-10 years after launch, and then decline. 4444 05/04/2013 Results New cancer drugs introduced during ...

Drug and Medication Market in The United Kingdom

  • Industry report
  • January 2014
  • 35 pages

... Issued appraisal guidance or the guidance has not yet been implemented for routine funding drug/indication combinations which nice is not going to consider. cancer drugs fund (cdf ...

Drug and Medication in The United States : Innovation and Technology Trends

  • Industry report
  • November 2013
  • 28 pages

... In old (pre-1991) drug expenditure $11 total value of benefits $95 conclusions the cost of new cancer drugs is less than 1% of the value of the mortality reduction they yielded pharmaceutical ...

Drug in Germany, Italy and The United States : Innovation and Technology Trends

  • Industry report
  • March 2012
  • 30 pages

... Changes in development and evaluation of new cancer drugs: what is needed to guide practice Wolf-dieter ludwig, m.D., Ph.D. Drug commission of the german medical association dept ...

Drug and Medication Market in Japan

  • Industry report
  • September 2012
  • 23 pages

... Merck oxaliplatin (elplat) anti-cancer drug (1980 S [fr], 2005 [jp]) nagoya city university (kitani) debiopharm (swiss) ( Yakult) celmoleukin (celeuk) anti-cancer drug (1992) osaka univ. (Taniguchi ...

Drug and Medication in The United Kingdom : Innovation and Technology Trends

  • Industry report
  • January 2014
  • 22 pages

... Medicine. 10(1), 61-72. Linley, w.G. And hughes, d.A. (2012) Societal views of nice, cancer drugs fund, and value based pricing criteria for prioritising medicines: a cross-sectional survey of 4118 adults ...

Pharmaceutical Business Brief

  • Industry report
  • November 2012
  • 2 pages

... Wsj november 12, 2012 not enough cancer drugs, too many price controls by bill cassidy and patrick w. Cobb cancer patients face daunting challenges, including side effects of treatment ...

» Purchase Premium Reports (From $ 125 - $ 12 375)

About 400 reports for Cancer Drug
Snap shot report of I/E analysis of Carbendazim

Snap shot report of I/E analysis of Carbendazim

  • $ 1 788
  • Industry report
  • April 2014
  • by CCM International Limited

To help clients have an overall understanding of import/export situation of Carbendazim. It is the analysis summary of Carbendazim's Import/Export analysis. It is published monthly and it would include ...


ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.